Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized HER2 targeting monoclonal antibody conjugated to a cytotoxic tubulin inhibitor amberstatin |
---|---|
Date Designated: | 01/14/2021 |
Orphan Designation: | Treatment of gastric cancer including cancer at the gastroesophageal junction |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ambrx, Inc. 10975 N. Torrey Pines Road La Jolla, California 92037 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-